Intermittent Hypoxia Initiated Motor Plasticity in Individuals With Multiple Sclerosis

RecruitingNot a drug-phase studyRelapsing and progressiveNCT06276634

What it found

Still running

No result yet.

What was tested

Treatment tested

  • Acute Intermittent Hypoxia

Placebo

  • Sham-Acute Intermittent Hypoxia

What it measured

Main measures

  • Ankle Plantarflexion Strength

    Before and following each 5-day intervention block

    Physical function

Other measures (1)

  • Task fMRI

    Before and following each 5-day intervention block

    Nerve conduction tests

Who could take part

Relapsing and progressive · 18 to 75

Show the full criteria

Inclusion criteria

* Diagnoses of relapsing form of MS (including relapsing-remitting MS and secondary-progressive MS) * Expanded Disability Status Scale (EDSS) score of at least 3 and no more than 6.5 * Motor Functional System Scale (FSS) between 2-4 * Relapse free for at least 1 year * Age ≥ 18 years and ≤ 75 years * Safe to be scanned based on MRI questionnaire * Participants using dalfampridine will be eligible if taking the same daily dose for at least 2 months prior to screening

Exclusion criteria

* Active contrast-enhancing MS lesions, or diffusion positive lesions suggestive of acute cerebrovascular disease on baseline MRI scan * Uncontrolled hypertension (Systolic between 85 and 140, diastolic between 90 and 55) * History of epilepsy * Chronic obstructive pulmonary disease * Uncontrolled Sleep apnea * Pregnancy

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

This study aims to understand the mechanisms of a novel intervention involving breathing short durations of low levels of oxygen for persons with multiple sclerosis (MS). This intervention with low levels of oxygen is called Acute Intermittent Hypoxia (AIH), the levels of oxygen experienced are similar to breathing the air on a tall mountain, for less than 1 minute at a time. Previous studies have shown that AIH is a safe and effective way to increase strength in persons with MS. Here the investigators aim to look at brain activation and ankle strength before and after AIH to gain a better understanding of how the AIH may improve strength in those persons with MS.

Papers

    Loading reviews and guidelines…

    History

      1. Started

        Apr 2024

      2. Main results due

        Nov 2025

      3. Finished

        Jan 2027

      Assembled by software from public sources.